Categories: News

ZetrOZ Shares Lessons Learned in Medical Technology with Med Device Online

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

TRUMBULL, Conn., May 25, 2021 /PRNewswire/ — In the most current article of Medical Device Online, Dr. George Lewis, creator of the ZetrOZ sustained acoustic medicine (SAM) system, shared his experiences of the obstacles keeping innovative medical technology from widespread use and ways medical device developers can surmount those challenges. 

“There are forces at work that are actively hindering the adoption of breakthrough medical technologies in favor of profit,” Lewis wrote.

SAM received FDA clearance in 2013, and more than 20 clinical studies show its efficacy in helping people manage pain and recover from both acute and chronic musculoskeletal injuries. 

In the article, Lewis details the “Chicken and the Egg Dilemma” involving doctors and insurers that stall adoption, discourage investment and stall innovation.

Lewis also outlines the strategies ZetrOZ has used to reach consumers and physicians and spur demand for its products and points to little-known legislation that may open the doors for developers of medical devices to receive reimbursement from both federal and private payers. 

Lewis concludes that, despite the challenges, there is a path forward for change. “Medical device developers must continue to innovate, educate, and inform the public about the breakthrough technologies that are not far off on the horizon,” he writes. “People will not settle for the status quo.”

The full article appeared on Medical Device Online on May 24, 2021.

To learn more about ZetrOZ and its SAM line of products, visit samrecover.com.

About ZetrOZ Systems:
ZetrOZ Systems is an FDA cGMP and ISO 13585 medical technology company headquartered in the southern coastal region of Connecticut. The organization also has manufacturing facilities across the United States. ZetrOZ Systems produced UltrOZ®, sam®Sport and sam®Pro 2.0 to provide safe and effective treatment options for prevalent conditions such as arthritis. Learn more at zetroz.com and samrecover.com.

Media Contact:
Bianca D’Angelo
(203) 577-7588 (Direct)
bianca@newswire.com
www.Newswire.com

Related Images

zetroz-ceo-dr-george-lewis.jpg
ZetrOZ CEO Dr. George Lewis

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/zetroz-shares-lessons-learned-in-medical-technology-with-med-device-online-301298766.html

SOURCE ZetrOZ Systems

Staff

Recent Posts

Cure by Deerfield Middle East Health Accelerator Opens in Qatar

Global Healthcare Startups Invited to Apply for 12-Week Program with Mentorship, Investor Exposure, and Pitch…

1 hour ago

Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Closes Over $500 Million Private Placement to Launch SOL Treasury Company

Preeminent SOL-backed treasury vehicle - with potential to raise over $1.25 billion aggregate gross proceeds…

1 hour ago

Clinical.ly Launches Research Working Group: From Sites, For Sites

NEW YORK, Sept. 18, 2025 /PRNewswire/ -- Clinical.ly, a leading provider of intuitive clinical research…

1 hour ago

Inmar Intelligence awarded pharmacy claims reconciliation and DSCSA compliance agreements with Premier, Inc.

WINSTON-SALEM, N.C., Sept. 18, 2025 /PRNewswire/ -- Inmar Intelligence, a leader in healthcare technology and…

1 hour ago

Talkiatry Recognized on TIME and Statista’s List of the World’s Top HealthTech Companies of 2025

Virtual psychiatry leader honored for redefining access, scale, and quality in mental health care through…

1 hour ago

Wellstar Health System Rolls Out the Swift™ AI Scheduling Copilot for Nursing Teams, the First Workforce Solution by vflok Inc.

ATLANTA, Sept. 18, 2025 /PRNewswire/ -- Workforce AI startup vflok™ Inc. is improving schedule flexibility…

1 hour ago